AgomAb Therapeutics N.V. American Depositary Shares (AGMB)

AgomAb Therapeutics N.V. American Depositary Shares (AGMB) scores 23 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $1845.53, representing a 14966% margin of safety. Quantitative score: 43/100. Qualitative score: 10/100.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full AGMB analysis on boothcheck